Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term results after surgical resection of intrahepatic cholangiocarcinoma before and since the BILCAP era.

Frontiers in surgery·2026
Same author

Accelign: a GPU-based library for accelerating pairwise sequence alignment.

BMC bioinformatics·2026
Same author

Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial.

The Lancet regional health. Europe·2026
Same author

Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

A novel endpoint for liver surgery predicts surgery-related mortality: external validation in a surgical cohort with intrahepatic cholangiocarcinoma.

Frontiers in surgery·2026
Same author

An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final Analysis.

Liver cancer·2026
Same journal

Correction to 'A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta-Analysis'.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same journal

Correction to 'Clinical Outcomes of MAFLD Versus NAFLD: A Meta-Analysis of Observational Studies'.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same journal

Correction to 'Programmed Cell Death 1 Genetic Variant and Liver Damage in Nonalcoholic Fatty Liver Disease'.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same journal

Emerging Immune-Based Therapeutic Strategies in Hepatocellular Carcinoma.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same journal

Case-Crossover Design Is Not Immune to All Unmeasured Confounders and Time-Trend Bias.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same journal

MASH-Related Liver Cancer Estimates Need Aetiology-Specific Validation in the Asia-Pacific Region.

Liver international : official journal of the International Association for the Study of the Liver·2026
See all related articles

Related Experiment Video

Updated: May 8, 2026

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

CellMinerHCC: a microarray-based expression database for hepatocellular carcinoma cell lines.

Frank Staib1, Markus Krupp, Thorsten Maass

  • 1Department of Medicine I, Johannes Gutenberg University, Mainz, Germany.

Liver International : Official Journal of the International Association for the Study of the Liver
|September 11, 2013
PubMed
Summary
This summary is machine-generated.

A new database, CellMinerHCC, provides gene expression profiles for 18 hepatocellular carcinoma (HCC) cell lines. This resource aids researchers in designing targeted therapies by detailing genetic specificities for in vitro experiments.

Keywords:
HCCbioinformaticsliver canceroncogenomicssystems biology

More Related Videos

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery
07:25

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Published on: August 18, 2023

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Related Experiment Videos

Last Updated: May 8, 2026

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery
07:25

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Published on: August 18, 2023

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Area of Science:

  • Genomics
  • Bioinformatics
  • Cancer Research

Background:

  • Therapeutic options for hepatocellular carcinoma (HCC) are limited.
  • Gene-targeted therapies offer a promising avenue for HCC treatment.
  • Understanding molecular biology through in vitro experiments is crucial, but variable treatment responses highlight the need for detailed cell line information.

Purpose of the Study:

  • To create a publicly accessible database of microarray gene expression profiles for diverse HCC cell lines.
  • To facilitate the design of in vitro experiments by providing comprehensive gene expression data.
  • To support the development of targeted therapies for HCC.

Main Methods:

  • Microarray data were analyzed using a custom R program package.
  • Data were stored in a PostgreSQL database with a PHP web interface.
  • A public web interface enables the evaluation and comparison of cell line expression profiles.

Main Results:

  • The database contains gene expression profiles for 18 HCC cell lines, allowing for differential gene expression comparisons.
  • Analysis revealed a liver tumor phenotype with enrichment in cancer and inflammatory response pathways.
  • Identified molecular associations of interest include 'lipid metabolism'.

Conclusions:

  • CellMinerHCC (http://www.medicalgenomics.org/cellminerhcc) is a new public database of gene expression data for 18 HCC cell lines.
  • This resource will assist in the design of in vitro experiments by accounting for the genetic specificities of HCC cell lines.
  • Facilitates more informed experimental design in HCC research.